SEARCH

SEARCH BY CITATION

Newly available commercial assays for angiotensin II type 1 receptor antibodies provide an opportunity for examining the role of non-HLA antibodies in kidney transplantation, but data do not yet support their widespread clinical use. See articles by Giral et al (page 2567) and Taniguchi et al (page 2577).